4 free views remaining today

obsolete autosomal dominant mental retardation 61

Description

Autosomal dominant mental retardation 61, also known as "mental retardation, autosomal dominant 61" (OMIM 616158), is an outdated term that was previously used to describe a condition characterized by intellectual disability and impaired adaptive behavior.

According to the available information [1], this condition was typically inherited in an autosomal dominant pattern, meaning that a single copy of the mutated gene was sufficient to cause the disorder. The condition was often associated with below-average intellectual functioning and impairments in adaptive behavior, such as difficulty with social interactions, communication, and daily living skills.

It's worth noting that the term "mental retardation" is now considered outdated and stigmatizing, and has been replaced by more respectful and accurate terms such as "intellectual disability" [2]. The condition itself was likely a result of genetic mutations or variations that affected brain development and function.

References: [1] Context 5 [2] Context 7

Additional Characteristics

  • intellectual disability
  • difficulty with social interactions
  • communication, and daily living skills

Signs and Symptoms

Based on the provided context, here are the signs and symptoms of Mowat-Wilson syndrome (MWS), which is an obsolete term for a specific type of autosomal dominant mental retardation:

  • Distinctive facial features: Widely spaced eyes, broad eyebrows with a medial flare, low-hanging columella, and other characteristic facial abnormalities [1][4].
  • Early-onset issues: Hypotonia (low muscle tone), hypothermia (low body temperature), hypersomnolence (excessive sleepiness), feeding difficulties, excessive hiccups, recurrent central apneas, and other early signs of the condition [2].

It's worth noting that Mowat-Wilson syndrome is a rare genetic disorder characterized by intellectual disability, dysmorphic facial features, delayed psychomotor development, and lack of speech. The symptoms can vary in severity and may include additional features not mentioned here.

References: [1] Mar 28, 2007 — Mowat-Wilson syndrome (MWS) is characterized by distinctive facial features... [2] Apr 27, 2017 — Early-onset issues can include hypotonia, hypothermia, hypersomnolence, feeding difficulties... [4] Mowat-Wilson syndrome (MWS) is characterized by distinctive facial features...

Additional Symptoms

  • Feeding difficulties
  • Distinctive facial features
  • Hypotonia (low muscle tone)
  • Hypothermia (low body temperature)
  • Hypersomnolence (excessive sleepiness)
  • Excessive hiccups
  • Recurrent central apneas

Diagnostic Tests

Based on the provided context, it appears that diagnostic tests for autosomal dominant intellectual developmental disorder-61 (MRD61) are related to genetic testing.

  • Genetic tests such as full gene sequencing panel and Next Generation Sequencing (NGS) can be used to identify the underlying cause of MRD61. [1][2]
  • The ADNP gene has been associated with MRD61, and testing for this gene may be recommended. [3]
  • Other genes such as MED13 have also been linked to MRD61, and genetic testing for these genes may be considered. [4]

It's worth noting that the diagnostic tests mentioned above are likely to be used in a research or clinical setting, and may not be widely available or up-to-date.

References: [1] Context 2 [2] Context 3 [3] Context 4 [4] Context 7

Additional Diagnostic Tests

  • Full gene sequencing panel
  • Next Generation Sequencing (NGS)
  • ADNP gene testing
  • MED13 gene testing

Treatment

Treatment Options for Autosomal Dominant Intellectual Developmental Disorder-61 (MRD61)

Autosomal dominant intellectual developmental disorder-61 (MRD61), also known as Mental Retardation, Autosomal Dominant 61, is a rare genetic neurodevelopmental disorder characterized by global developmental delay and variable degrees of intellectual disability.

Unfortunately, there are no specific drug treatments mentioned in the search results for MRD61. However, some general information on treatment approaches for related conditions can be found:

  • No specific treatment: The search results do not mention any specific drug treatment or therapy for MRD61.
  • General developmental support: Children and adolescents with intellectual disabilities, including those with MRD61, often benefit from early intervention and supportive therapies such as speech, occupational, and physical therapy (1).
  • Genetic counseling: Genetic counseling may be recommended to discuss the inheritance pattern of the condition and provide guidance on reproductive options (2).

It's essential to consult with a healthcare professional for personalized advice and treatment. They can help determine the best course of action based on individual needs and circumstances.

References:

(1) [3] - This search result mentions that children and adolescents with intellectual disabilities benefit from early intervention and supportive therapies. (2) [4] - Genetic counseling may be recommended to discuss the inheritance pattern of MRD61.

Recommended Medications

  • No specific treatment
  • General developmental support

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Based on the provided context, it appears that the differential diagnosis for obsolete autosomal dominant mental retardation 61 (MRD61) should consider other disorders with intellectual disability without distinctive findings.

  • Disorders with intellectual disability without other distinctive findings should be considered in the differential diagnosis [1].
  • All disorders with intellectual disability without other distinctive findings should be considered in the differential diagnosis, including MRD61.
  • The OMIM designation for PURA-related neurodevelopmental disorders – "mental retardation, autosomal dominant 31" (OMIM 616158) – is no longer in use, but it may still be relevant to consider in the differential diagnosis of MRD61.

Other conditions that may be considered in the differential diagnosis of MRD61 include:

  • Intellectual developmental disorder, autosomal dominant 41 [2]
  • PURA-related neurodevelopmental disorders
  • Other genetic conditions leading to intellectual disability and growth retardation [6]

It's worth noting that the classification of mental retardation (MR) into different categories is determined by the extent of the handicap instead of its cause, which often remains unrecognized [4]. Therefore, a comprehensive evaluation of the individual's clinical history, physical examination, and laboratory findings is essential to establish an accurate diagnosis.

References: [1] Context 1 [2] Context 2 [4] Context 4 [6] Context 6

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_2599
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0080229
core#notation
DOID:0080229
rdf-schema#label
obsolete autosomal dominant mental retardation 61
owl#deprecated
true
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.